Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL, Parolo E, Pellegrini JAS, Viana MV, Schwarz P, Lisboa TC, Dora JMS, Portich JP, Paz AA, Silla L, Balsan AM, Schirmer FD, Franz JPM, da-Silveira LM, Breunig RC, Petersen V, Sosnoski M, Mesquita NF, Volpato FCZ, Sganzerla D, Falavigna M, Rosa RG, Zavascki AP; PLACOVID Study Group. Sekine L, et al. Among authors: silla l. Eur Respir J. 2022 Feb 10;59(2):2101471. doi: 10.1183/13993003.01471-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 34244316 Free PMC article. Clinical Trial.
Characterization of Patients with Chronic Myeloid Leukemia Unresponsive to Tyrosine Kinase Inhibitors Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
Carvalho FR, Zuckermann J, Paz A, Fischer G, Daudt LE, Rigoni LD, Silla L, Fogliatto L, de Castro SM, Pilger DA. Carvalho FR, et al. Among authors: silla l. Int J Hematol Oncol Stem Cell Res. 2017 Jan 1;11(1):30-36. Int J Hematol Oncol Stem Cell Res. 2017. PMID: 28286612 Free PMC article.
Adoptive immunotherapy with double-bright (CD56bright /CD16bright ) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study.
Silla L, Valim V, Pezzi A, da Silva M, Wilke I, Nobrega J, Vargas A, Amorin B, Correa B, Zambonato B, Scherer F, Merzoni J, Sekine L, Huls H, Cooper LJ, Paz A, Lee DA. Silla L, et al. Br J Haematol. 2021 Dec;195(5):710-721. doi: 10.1111/bjh.17751. Epub 2021 Sep 7. Br J Haematol. 2021. PMID: 34490616 Clinical Trial.
Patient socioeconomic status as a prognostic factor for allo-SCT.
Silla L, Fischer GB, Paz A, Daudt LE, Mitto I, Katz B, da Graça Grossini M, Bittencourt HN, Jochims A, Fogliatto L, Bittar CM, Friedrisch JR, Bittencourt RI. Silla L, et al. Bone Marrow Transplant. 2009 Apr;43(7):571-7. doi: 10.1038/bmt.2008.358. Epub 2008 Nov 3. Bone Marrow Transplant. 2009. PMID: 18978820
Survival and graft-versus-host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from HLA-matched related donor: retrospective analysis of 334 consecutive patients.
Campregher PV, Hamerschlak N, Colturato VA, Mauad MA, de Souza MP, Bouzas LF, Tavares Rde C, Barros JC, Chiattone R, Paz A, Silla L, Vigorito AC, Miranda E, Funke VA, Flowers ME. Campregher PV, et al. Among authors: silla l. Eur J Haematol. 2015 Nov;95(5):421-5. doi: 10.1111/ejh.12508. Epub 2015 Feb 19. Eur J Haematol. 2015. PMID: 25645430
Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil.
Paz A, Rigoni L, Fischer G, Schittler M, Pezzi A, Valim V, Dahmer A, Zambonato B, Amorin B, Sehn F, Silva MAD, Daudt L, Silla L. Paz A, et al. Among authors: silla l. Hematol Transfus Cell Ther. 2018 Apr-Jun;40(2):136-142. doi: 10.1016/j.htct.2017.11.008. Epub 2018 Feb 17. Hematol Transfus Cell Ther. 2018. PMID: 30057987 Free PMC article.
70 results